Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NYSE | Common Stock
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
In addition, it distributes human cell, tissue, and cellular and tissue-based products.
The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents.
Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 7, 24 | 0.72 Increased by +35.85% | 0.57 Increased by +26.32% |
| Feb 20, 24 | 0.60 Increased by +1.69% | 0.61 Decreased by -1.64% |
| Nov 7, 23 | 0.57 Increased by +14.00% | 0.57 |
| Aug 3, 23 | 0.63 Increased by +12.50% | 0.59 Increased by +6.78% |
| May 4, 23 | 0.53 Increased by +26.19% | 0.51 Increased by +3.92% |
| Feb 21, 23 | 0.59 Increased by +20.41% | 0.56 Increased by +5.36% |
| Nov 8, 22 | 0.50 Increased by 0.00% | 0.52 Decreased by -3.85% |
| Aug 4, 22 | 0.56 Increased by 0.00% | 0.53 Increased by +5.66% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 383.64 M Increased by +50.95% | 998.00 K Decreased by -97.90% | Increased by +0.26% Decreased by -98.61% |
| Jun 30, 23 | 291.62 M Increased by +10.61% | 57.71 M Increased by +5.72% | Increased by +19.79% Decreased by -4.42% |
| Mar 31, 23 | 276.69 M Increased by +20.01% | 49.13 M Increased by +29.00% | Increased by +17.76% Increased by +7.49% |
| Dec 31, 22 | 274.50 M Increased by +9.79% | 50.06 M Increased by +231.42% | Increased by +18.24% Increased by +201.87% |
| Sep 30, 22 | 254.15 M Increased by +10.63% | 47.43 M Increased by +0.47% | Increased by +18.66% Decreased by -9.19% |
| Jun 30, 22 | 263.65 M Increased by +5.03% | 54.59 M Increased by +31.40% | Increased by +20.71% Increased by +25.10% |
| Mar 31, 22 | 230.55 M Increased by +1.41% | 38.08 M Decreased by -15.98% | Increased by +16.52% Decreased by -17.15% |
| Dec 31, 21 | 250.02 M Increased by +7.10% | 15.11 M Decreased by -71.47% | Increased by +6.04% Decreased by -73.37% |